WHITEHOUSE STATION, N.J. ? Drugmaker Merck & Co. has swung to a fourth-quarter profit because of lower acquisition and restructuring charges and slightly higher sales.
The maker of allergy and asthma drug Singulair says net income was $1.51 billion, or 49 cents per share. A year earlier, Merck lost $531 million, or 17 cents a share.
Adjusted income was $2.98 billion, or 97 cents a share, up from $2.76 billion, or 88 cents a share. The earnings topped expectations for 95 cents per share.
Revenue rose 1.6 percent $12.29 billion, short of expectations for $12.52 billion.
Merck forecast 2012 earnings per share of $3.75 to $3.85, excluding charges. Analysts expect $3.83.
THIS IS A BREAKING NEWS UPDATE. Check back soon for further information. AP's earlier story is below.
WHITEHOUSE STATION, N.J. (AP) ? Drugmaker Merck & Co. has swung to a fourth-quarter profit because of lower acquisition and restructuring charges and slightly higher sales.
The maker of allergy and asthma drug Singulair says net income was $1.51 billion, or 49 cents per share. A year earlier, Merck lost $531 million, or 17 cents a share.
Adjusted income was $2.98 billion, or 97 cents a share, up from $2.76 billion, or 88 cents a share. The earnings topped expectations for 95 cents per share.
Revenue rose 1.6 percent $12.29 billion, short of expectations for $12.52 billion.
Merck forecast 2012 earnings per share of $3.75 to $3.85, excluding charges. Analysts expect $3.76.
(This version CORRECTS analyst expectations figure in final pararaph to $3.83.)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.